Enhanced CEA-specific Immune Responses by Tat-LLO Fusion Protein |
Yi, Soon-Aei
(Department of Microbiology and Immunology, The Catholic University of Korea)
Sohn, Hyun-Jung (Department of Microbiology and Immunology, The Catholic University of Korea) Kim, Chang-Hyun (Department of Microbiology and Immunology, The Catholic University of Korea) Park, Mi-Young (Department of Microbiology and Immunology, The Catholic University of Korea) Oh, Seong-Taek (Department of Surgery, College of Medicine, The Catholic University of Korea) Kim, Tai-Gyu (Department of Microbiology and Immunology, The Catholic University of Korea) |
1 | Kass E, Schlom I. Thompson I. Guadagni F, Graziano Greiner TW: Induction of protective host immunity to cinoernbrvonic antigen (CEA), a self-antigen in CEA trans nic mice, by immunizing with a recombinant vaccinia-C virus. Cancer Res 1;59:676-683, 1999 |
2 | Rubartelli A, Poggi A, Sitia R, Zocchi MR: HIV-I Tat: a p peptide for all seasons. Immunol Today 19;543-545, 1998 DOI ScienceOn |
3 | Wang W, El-Deiry WS: Targeting p53 by PTD-mediated transduction, Trends Biotechnol 22;431-434, 2004 DOI ScienceOn |
4 | Cho HI, Kim HJ. Oh ST, Kim TG: In vitro induction of cinoernbrvonic antigen (CEA)-specific cytotoxic T lymp cytes by dendritic cells transduced with recombinant ade viruses. Vaccine 22;224-236, 2003 DOI ScienceOn |
5 | Lima J. Tenkins C, Guerrero A, Triozzi PL, Shaw DR, St TV: A DNA vaccine encoding genetic fusions of carcin embryonic antigen (CEA) and granulocyte/macrophage co nv-stimulatina factor (GM-CSF). Vaccine 23;1273-1283, 2005 DOI ScienceOn |
6 | Boon T, Cerottini TC, Van den Evnde B, van der Bruggen Van Pel A: Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12;337-365, 1994 DOI ScienceOn |
7 | You YH, Hefta LT, Yazaki PI. Wu AM, Shively TE: Ex ssion, purification, and characterization of a two domain cinoernbrvonic antigen minizene (N-A3) in oicbia pastoris, essential role of the N-domain. Anticancer Res 18;3193-32 1998 PUBMED |
8 | Hellwig S, Robin F, Drossard T, Raven NP, Vacuero-Ma C, Shively TE, FischerR: Production of carcinoernbrvonic tizcn (CEA) N-A3 domain in Pichia tiastoris by fermentation. Biotechnol Appl Biochem (Pt 3) 267-275, 1999 |
9 | Frankel AD, Pabo CO: Cellular uptake of the tat pro from human immunodeficiency virus. Cell 55;1189-11 1988 DOI ScienceOn |
10 | 원은하, 김창현, 박미영, 조현일, 오승택, 홍용길, 김태규 CEA 발현 수지상세포를 이용한 CEA 특이 살해 T세포의 유도. Immune Network 3;295-301, 2003 DOI |
11 | Ye L, Bu Z, Skeen MT, Ziegler HK, Compans RW, Y C: Enhanced immunocenicitv of SIV Gag DNA vaccin encoding chimeric proteins containing a C-terminal segm of Listeriolvsin O. Virus Res 97;7-16, 2003 DOI ScienceOn |
12 | Sewell DA, Shahabi V, Gunn GR 3rd, Pan ZK, Dominiecki ME, Paterson Y: Recombinant Listeria vaccines containing PEST sequences are potent immuneadiuvants for the tumor- associated antigen human papillomavirus-16 E7. Cancer Res 64;8821-8825, 2004 DOI ScienceOn |
13 | Germain RN: The biochemistry and biology of antigen sentation by MHC class I and class II molecules: impli tions for development of combination vaccines. Ann N Y Acad Sci 754;114-125, 1995 DOI PUBMED ScienceOn |
14 | 안창혁, 강원경, 오승택, 조현일, 김태규: CEA와 Tat융합 단백질을 이용한 CEA 특이 항종양 면역능의 유도 증가. J Korean Soc Coloproctol 19;121-128, 2003 |
15 | Mandal M, Lee KD: Listeriolvsin Odioosome-mediated cv solie delivery of macromolecule antigen in vivo: enhancem of antigen-specific cytotoxic T lymphocyte frequency activ and tumor protection. Biochim Biophvs Acta 1563;7-17, 2002 DOI ScienceOn |
16 | Giammarini C, Andreoni F, Amazliani G, Casiere A, Bar S, Magnani M: Purification and characterization of a reco binant listeriolvsin O expressed in Escherichia coli and pos diagnostic applications. J Biotechnol 109;13-20, 2004 DOI PUBMED ScienceOn |
17 | Lety MA, Frehel C, Dubail I, Beretti TL. Kaval S, Berche Charbit A: Identification of a PEST-like motif in listeriolv o required for phazosornal escape and for virulence in L teria monocvtozenes. Mol Microbiol 39;1124-1139, 2001 DOI ScienceOn |
18 | Kim DT, Mitchell DT, Brockstedt DG, Fong L, Nolan G Fathrnan CG, Engleman EG, Rothbard TB: Introduction soluble proteins into the MHC class I pathway by coniu tion toan HIV tat peptide. J Immunol 159;1666-1668, 1997 PUBMED |
19 | Nakamura T, Tanaka T, Takagi H, Sato M: Cloning and terozeneous in vivo expression of Tat binding protein (TBP-1) inthe mouse. Biochim Biophys Acta 399;93-10 1998 |
20 | Thompson TA, Grunert F, Zimmermann W: Carcinoemb nic antigen gene family: molecular biology and clinical spectives, J Clin Lab 5;344-366, 1991 DOI PUBMED |
21 | Bradford MM: A rapid and sensitive method for the quant tion of microgram quantities of protein utilizing the prine of protein-dye binding. Anal Biochem 72;248-254, 1976 DOI PUBMED ScienceOn |
22 | Portnoy DA, Jones S: The cell biology of Listeria monocy infection (escape from a vacuole). Ann N Y Acad Sci 730; 15-25, 1994 DOI PUBMED |
23 | Giammarini C, Andreoni F, Arnaaliani G, Casiere A, Bar S, Magnani M: High-level expression of the Listeria m cvtosenes listeriolvsin O in Escherichia coli and preliminar racterization of the purified protein. Protein Expr Purif 28;78-85, 2003 DOI ScienceOn |
24 | Fawell S, Seery I. Daikh Y, Moore C, Chen LL, Pepin B, Barsoum T: Tat-mediated delivery of heterologous prote into cells. Proc Natl Acad Sci USA 91;664-668, 1994 |
25 | Timmerman JM, Levy R: Dendritic cell vaccines for can immunotherapy. Annu Rev Med 50;507-529, 1999 DOI ScienceOn |
26 | Beauregard KE, Lee KD, Collier RI. Swanson TA: pH-dep dent perforation of macrophage ohazosornes by listeriolv O from Listeria monocvtooenes, J Exp Med 186:1159-1163, 1997 DOI ScienceOn |